Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Horak

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Molecular Immunology|August 17, 1999
Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysisA M McCall, G P Adams, A R Amoroso, et al.
Ecotoxicology (London, England)|January 10, 2012
Assessment of toxicity and potential risk of the anticoagulant rodenticide diphacinone using Eastern screech-owls (Megascops asio)Barnett A Rattner, Katherine E Horak, Rebecca S Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancerShirin Khambata-Ford, Christopher T Harbison, Lowell L Hart, et al.
Cancer Research|December 20, 2007
Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2Christine E Horak, Arnulfo Mendoza, Eleazar Vega-Valle, et al.
British Journal of Cancer|October 9, 2008
Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitroM K Robinson, K M Hodge, E Horak, et al.
BMC Research Notes|February 3, 2018
Grass is not always greener: rodenticide exposure of a threatened species near marijuana growing operationsAlan B Franklin, Peter C Carlson, Angela Rex, et al.
Journal of the National Cancer Institute|August 23, 2012
Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancerJean-Claude A Marshall, Joshua W Collins, Joji Nakayama, et al.
Journal of the National Cancer Institute|May 5, 2005
Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancerDiane Palmieri, Douglas O Halverson, Taoufik Ouatas, et al.
Evolutionary Applications|April 22, 2026
The LAST Mile: Evaluating Genetic Biocontrol as a Supplemental Tool for Eradicating Invasive Rodents on IslandsAysegul Birand, Bruce A Hay, Matthew Combs, et al.
Cancer Research|August 3, 2007
Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2Christine E Horak, Jong Heun Lee, Abdel G Elkahloun, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Molecular Immunology|August 17, 1999
Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysisA M McCall, G P Adams, A R Amoroso, et al.
Ecotoxicology (London, England)|January 10, 2012
Assessment of toxicity and potential risk of the anticoagulant rodenticide diphacinone using Eastern screech-owls (Megascops asio)Barnett A Rattner, Katherine E Horak, Rebecca S Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancerShirin Khambata-Ford, Christopher T Harbison, Lowell L Hart, et al.
Cancer Research|December 20, 2007
Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2Christine E Horak, Arnulfo Mendoza, Eleazar Vega-Valle, et al.
British Journal of Cancer|October 9, 2008
Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitroM K Robinson, K M Hodge, E Horak, et al.
BMC Research Notes|February 3, 2018
Grass is not always greener: rodenticide exposure of a threatened species near marijuana growing operationsAlan B Franklin, Peter C Carlson, Angela Rex, et al.
Journal of the National Cancer Institute|August 23, 2012
Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancerJean-Claude A Marshall, Joshua W Collins, Joji Nakayama, et al.
Journal of the National Cancer Institute|May 5, 2005
Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancerDiane Palmieri, Douglas O Halverson, Taoufik Ouatas, et al.
Evolutionary Applications|April 22, 2026
The LAST Mile: Evaluating Genetic Biocontrol as a Supplemental Tool for Eradicating Invasive Rodents on IslandsAysegul Birand, Bruce A Hay, Matthew Combs, et al.
Cancer Research|August 3, 2007
Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2Christine E Horak, Jong Heun Lee, Abdel G Elkahloun, et al.
Pageof 12